Irepertoire Inc.

Huntsville, AL

UEI
GT35KNG2JGF4
CAGE
5EE39
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
Huntsville, AL 35806, USA
Website
irepertoire.com
Founded
2009
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Irepertoire Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
RNA sequencing services for mouse t cell receptor Contract · 75N93024P01168 National Institute of Allergy and Infectious Diseases $13,230
PCR amplification services and sequencing services (ambis #2232629) Contract · 75N93024P01115 National Institute of Allergy and Infectious Diseases $22,932
Immune repertoire sequencing Contract · 75N93024P00525 National Institute of Allergy and Infectious Diseases $19,272
Irepertoire, INC. T-cell receptor sequencing services Contract · 75N93024P00446 National Institute of Allergy and Infectious Diseases $19,404
T cell receptor deep sequencing service Contract · 75N93024P00225 National Institute of Allergy and Infectious Diseases $19,620

About Irepertoire Inc.

Irepertoire Inc. is a small disadvantaged business specializing in advanced molecular biology and immunological research services, primarily focusing on immune system analysis and sequencing technologies. Registered in SAM.gov since April 2009, the company operates as a for-profit corporate entity with extensive experience in providing sophisticated scientific research services to federal agencies. While limited public information is available about the company's full background, its federal contract history demonstrates a strong expertise in cutting-edge immunological research techniques, particularly in T-cell receptor sequencing and related molecular analysis.

The company has consistently secured federal contracts from multiple civilian agencies, with a primary concentration on health-related research institutions. Irepertoire Inc. has been awarded numerous purchase orders and definitive contracts from agencies such as the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), Veterans Health Administration (VHA), Centers for Disease Control and Prevention (CDC), and the National Eye Institute. Its core services include T-cell receptor sequencing, RNA extraction, PCR amplification, deep immune repertoire sequencing, and advanced laboratory testing services. The contracts, ranging in value from approximately $4,680 to $45,800, typically involve specialized research supporting immunological, infectious disease, and cancer research efforts. All of these contracts have been awarded without specific set-aside designations, indicating the company's competitive capabilities in securing federal research support across various scientific domains.

SBA capabilities narrative

iRepertoire, Inc., supplies products and services for the molecular analysis of the immune system using next-generation sequencing (NGS). These services include cell sorting, nucleic acid extraction, immune repertoire amplification, and NGS on Illumina systems. We also recently introduced single cell services for the pairing of receptor V(D)J rearrangements for human TCR alpha, beta, and immunoglobulin heavy and light chains. These technologies can be applied to a wide array of immune-based areas including autoimmunity, cancer research, and infectious disease. Our single cell technology is particularly applicable to immune-based drug development and can detect paired V(D)J rearrangements for rare populations of cells.

Quick answers

What is Irepertoire Inc.'s UEI?

Irepertoire Inc.'s Unique Entity ID (UEI) in SAM.gov is GT35KNG2JGF4.

What is Irepertoire Inc.'s CAGE code?

Irepertoire Inc.'s CAGE code is 5EE39.

What is Irepertoire Inc.'s primary NAICS code?

Irepertoire Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Irepertoire Inc. located?

Irepertoire Inc.'s physical address in SAM.gov is Huntsville, AL 35806, USA.

Is Irepertoire Inc. registered in SAM.gov?

Yes. Irepertoire Inc.'s SAM.gov registration is active through May 15, 2027.

What is Irepertoire Inc.'s most recent federal award?

Irepertoire Inc.'s most recent federal contract award is RNA sequencing services for mouse t cell receptor (75N93024P01168), from National Institute of Allergy and Infectious Diseases, on September 17, 2024.

On GovTribe

See Irepertoire Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors